The Part D benefit redesign portion of the Inflation Reduction Act (IRA) will begin in 2024 and fully implemented in 2025. This session will review the IRA provisions that affect infusion providers including an update on the drug price negotiations, copay caps, and how the Medicare Transaction Facilitator could impact cash flow.